Scope of the Study
Diagnostics PCR (polymerase chain reaction) is a technology which is used to strengthen particular DNA in a test tube. After the reaction, amplified DNA are analyzed using thermal cycler instrument. PCR technology is gaining traction owing to growing number of regular pathogens detection. Growing technical advancement in PCR technology has led to emergence of digital PCR devices, which further bolstered the market.
The market study is being classified by Type (Digital PCR, Multiple PCR, Other PCR and Others), by Application (Infection Disease Diagnosis, Cancer, Cardiovascular Disease (CVD), Genetic Testing, Drug Metabolism, HLA Type Test and Other Clinical Application) and major geographies with country level break-up.
Abbott Laboratories (United States), Agilent Technologies Inc. (United States), Alere Inc. (United States), Asuragen, Inc.(United States), Biocartis Group Nv (Belgium), Biomerieux Sa (France), Bio-Rad Laboratories, Inc. (United States), Genmark Diagnostics, Inc. (United States), Hologic, Inc. (United States), Luminex Corporation (United States) and Meridian Bioscience, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Qiagen N.V. (Germany), Quantumdx Group (United Kingdom), Roche Holding AG (Switzerland), Spartan Bioscience (Canada) and T2 Biosystems (United States).
Research Analyst at AMA predicts that American Players will contribute to the maximum growth of Global Diagnostics PCR market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Diagnostics PCR market by Type, Application and Region.
On the basis of geography, the market of Diagnostics PCR has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Growing Human Genome Project Research Activities
- Increasing prevalence of Bio-marker Profiling in Disease Diagnostic
- Continuous Technical Advancement in PCR Technologies
- Digitization of PCR Devices
- High Cost Associated with Diagnostics PCR Processes
- Technical Limitations of PCR Processes in Certain Applications
- Development of Portable, Lab-On-Chip PCR Devices
- Technology Integration with PCR Processes
- Implementation of Miqe Guidelines in Quantitative Real-Time PCR Experiments (MIQE) Guidelines
Key Target AudienceDiagnostics PCR Companies, End-user Industries, Market and Research Firms, Government Agencies and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase